Published: October 27, 2026
Excelra has announced the integration of the bioinformatics services of Fios Genomics Ltd and the team behind them into Excelra, effective October 20, 2026. The move strengthens Excelra’s omics analytics capabilities and expands its scientific consulting presence in the UK and Europe.
Based in Edinburgh, Scotland, Fios Genomics brings nearly two decades of experience in bioinformatics analysis and biological interpretation, helping pharmaceutical, biotechnology, and life sciences researchers translate complex omics data into actionable scientific insights.
The team joins Excelra’s scientific consulting group and will continue supporting Fios clients with the same scientists and established platform, backed by Excelra’s broader data science, AI engineering, and scientific informatics capabilities.
Strengthening Multi-Omics and Scientific Consulting
The integration combines Fios Genomics’ expertise in study-level omics analysis with Excelra’s capabilities in bioinformatics, AI-driven research, and scientific data solutions. This expanded expertise will help researchers derive deeper insights from complex biological datasets and support decision-making across drug discovery and development.
By bringing together complementary scientific and technical capabilities, Excelra aims to help life sciences organizations address critical research questions, including target identification, indication selection, and patient stratification.
Leadership Perspectives
“This is about continuity and making a larger impact for our clients,” said Sarah Lynagh, CEO of Fios Genomics. “Fios has always been defined by the quality of its science and the care we take with each study. Excelra shares those values and brings the wider data science and scientific informatics capability to do more for the researchers we work with.”
“Fios is known for rigorous, study-level analysis delivered quickly and explained clearly, exactly what researchers need when a dataset lands,” said Jannick Bendtsen, Vice President – Bioinformatics at Excelra. “That way of working fits naturally with our focus on integrative multi-omics, translational insight, and scientific AI. The team now has Excelra’s data assets, AI engineering, and a far larger pool of domain specialists behind it.”
“Fios has built a team of bioinformaticians that clients trust with their hardest questions, and we are delighted to welcome them to Excelra,” said Anandbir Singh Brar, CEO of Excelra. “Omics data keeps growing, but the questions don’t change: which target? which indication? which patients? Pairing Fios’ scientific depth with our own bioinformatics, data, and AI-native engineering means we can answer those questions even faster and with more confidence.”
Official Press Release
For more details about this announcement and the latest updates, explore the original press release
Continued Support for Fios Genomics Clients
Fios Genomics clients will continue working with the same scientific team and platform, with access to Excelra’s broader scientific consulting and informatics expertise.
For enquiries, contact the team at team.fiosgenomics@excelra.com.
About Excelra
Excelra engineers trust into AI-driven R&D by combining AI-ready data and platforms, including GOSTAR, connected lab informatics, and multi-omics expertise. Its solutions help life sciences organizations turn R&D complexity into informed, defensible decisions.
About Fios Genomics
Founded in 2008 as a spin-out from the University of Edinburgh, Fios Genomics provides bioinformatics analysis and biological interpretation across genomics, transcriptomics, and multi-omics studies for pharmaceutical, biotechnology, and life sciences researchers worldwide.
Media Contact
Prashant Sharma
Email: contact@excelra.com
